Alpha-1 Organisation Australia Incorporated

Alpha-1 Organisation Australia Incorporated (A1OA) is a proactive charity committed to supporting Australians affected by Alpha-1 Antitrypsin Deficiency (A1AD). With a mission to provide vital support and advocate for advancements in education and research, A1OA is dedicated to finding a cure for this genetic condition. Their vision is rooted in a commitment to the prevention and control of A1AD through public awareness, health professional education, identifying and supporting those affected, and advocating for effective treatments.

Main Objectives

A1OA focuses on several key objectives: enhancing public awareness about A1AD, educating health professionals, identifying and supporting individuals affected by this condition, and advocating for treatment options. These objectives are aimed at reducing the devastating impact of A1AD on individuals and their families throughout Australia.

Benefiting Groups

The primary groups benefiting from the organisation’s efforts include Australians diagnosed with A1AD, their families, healthcare providers, and researchers. A1OA serves as the primary point-of-contact for patients, carers, and medical professionals, fostering collaborations to expedite charity objectives.

Services and Activities

Alpha-1 Organisation Australia offers a range of services and activities including volunteer opportunities, membership with access to resources and newsletters, and direct involvement in advocacy initiatives. The organisation also supports clinical trials, which facilitate the development of potential treatments for A1AD. Importantly, A1OA provides mental health support services to assist individuals coping with the emotional challenges of a diagnosis.

Engagement with Alpha-1 Organisation Australia can be through volunteering, becoming a member, or making a donation to aid their efforts in awareness-building and family support. The organisation encourages individuals to stay informed through their newsletters and participate actively in ongoing and future initiatives. Passionately driven, A1OA continues to work rigorously towards its eventual goal of discovering a cure for Alpha-1 Antitrypsin Deficiency.